Abstract
Platelet-activating factor (PAF) is a lipid mediator formed in the early response of the central nervous system to ischemia or convulsions. Free polyunsaturated fatty acids and arachidonic and docosahexaenoic acids are accumulated along with PAF. Antagonists of PAF have been found to improve cerebral blood flow and partially block the rise in free fatty acids, an effect that may arise by way of inhibition of PAF receptors or stimulation of the reacylation of free fatty acids released upon insult. Three intracellular PAF-binding sites have been identified in rat cerebral cortex. These very high-affinity binding sites are inhibited by PAF antagonists, with certain antagonists exhibiting specificity for a particular binding site. This specificity indicates heterogeneity in these binding sites. Ischemia or stimulation also leads to protooncogene transcriptional activation. Here, we discuss studies with cells in culture showing that PAF promotes transcriptional activation of immediate-early genes. PAF activates the transcription of the immediate-early genesfos andjun, whose gene products are regulators of the transcription of other genes. Transcription offos is also activated by convulsion or ischemia in the central nervous system. The activation of these genes by PAF can be inhibited by PAF antagonists, and is apparently accomplished by way of an AP-1 transcription regulatory sequence in the promoter region of the target genes. Studies with deletion mutants show that PAF can also exert its activating properties by way of cyclic adenosine-3′,5′-monophosphate-(cAMP) and Ca2+-responsive elements, and suggest that PAF is involved in an interconnected network of cell signaling that may coordinate short-term and long-term responses of cells to stimulus and injury.
Similar content being viewed by others
Abbreviations
- AGEPC:
-
1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine
- B max :
-
binding sites density
- cAMP:
-
cyclic adenosine-3′,5′-monophosphate
- CNS:
-
central nervous system
- DSE:
-
dyad symmetry element
- FFA:
-
free fatty acids
- GPC:
-
glycerophosphocholine
- HIV-1:
-
human immunodeficiency virus-1
- IC50 :
-
50% inhibitory concentration
- K D :
-
rate of dissociation
- K i :
-
inhibitor constant
- LTR:
-
long terminal repeat
- mRNA:
-
messenger ribonucleic acid
- PAF:
-
platelet-activating factor
- PLA2 :
-
phospholipase A2
- PMA:
-
phorbol myristate acetate
- PUFA:
-
polyunsaturated fatty acids
- SRE:
-
serum response element
References
Bazan, N.G. (1970)Biochim. Biophys. Acta 218, 1–10.
Bazan, N.G., and Birkle, D.L. (1987) inMolecular Mechanisms of Neuronal Responsiveness (Ehrlich, Y., Lennox, R.H., Kornecki, E., and Berry, W.O., eds.), pp. 45–68, Plenum Press, New York.
Bazan, N.G., Birkle, D.L., Tang, W., and Reddy, T.S. (1986)Adv. Neurol. 44, 879–902.
Aveldano, M.I., and Bazan, N.G. (1975b)J. Neurochem. 25, 919–920.
Aveldano, M.I., and Bazan, N.G. (1975b)Brain Res. 100, 99–110.
Cenedella, R., Galli, C., and Paoletti, R. (1975)Lipids 10, 290–293.
Bosisio, E., Galli, C., Galli, G., Nicosia, S., Spagnuolo, C., and Tosi, L. (1976)Prostaglandins 11, 773–781.
Yoshida, S., Inoh, S., Asano, T., Sano, K., Kubota, M., Shimazaki, H., and Ueta, N. (1980)J. Neurosurg. 53, 323–331.
Siesjo, B.K., Ingvar, M., and Westerberg, E. (1982)J. Neurochem. 39, 796–802.
Lazarewicz, J.W., Leu, V., Sun, G.Y., and Sun, A.Y. (1983)Neurochem. Int. 5, 471–478.
Ikeda, M., Yoshida, S., Busto, R., Santiso, M., and Ginsberg, M. (1986)J. Neurochem. 47, 123.
Politi, L.E., Rodriguez de Turco, E.B., and Bazan, N.G. (1985)Neurochem. Pathol. 3, 249–269.
Bazan, N.G. (1971)Lipids 6, 211–212.
Aveldano, M.I., and Bazan, N.G. (1974)FEBS Lett. 40, 53–56.
Birkle, D.L., and Bazan, N.G. (1987)Biochim. Biophys. Acta 795, 564–573.
Birkle, D.L., and Bazan, N.G. (1987)J. Neurochem. 48, 1768–1778.
Bazan, N.G. (1976) inFunction and Metabolism of Phospholipids in the Central and Peripheral Nervous System (Porcellati, G., Amaducci L., and Galli C., eds.), Vol. 72, pp. 317–335, Plenum Press, New York.
Bazan, N.G., and Rodriguez de Turco, E.B. (1980)Adv. Neurol. 28, 197–205.
Bazan, N.G., and Rakowski, H. (1970)Life Sci. 9, 501–507.
Edgar, A.D., Strosznajder, J., and Horrocks, L.A. (1982)J. Neurochem. 39, 1111–1116.
Reddy, T.S., and Bazan, N.G. (1987)J. Neurosci. Res. 18, 449–455.
Marion, J., and Wolfe, L. (1978)Prostaglandins 16, 99–110.
Aveldano de Caldironi, M.I., and Bazan, N.G. (1979)Neurochem. Res. 4, 213–221.
Panetta, T., Marcheselli, V.L., Braquet, P., Spinnewyn, B., and Bazan, N.G. (1987)Biochem. Biophys. Res. Commun. 149, 580–587.
Birkle, D., Kurian, P., Braquet, P., and Bazan, N.G. (1988)J. Neurochem. 151, 88–109.
Bazan, N.G. (1989)Ann. N.Y. Acad. Sci. 559, 1–16.
Braquet, P., Shen, T.Y., Touqui L., and Vargaftig, B.B. (1987)Pharmacol. Rev. 39, 97–145.
Kumar, R., Harvey, S.A.K., Kester, M., Hanahan, D.J., and Olson, M.S. (1988)Biochim. Biophys. Acta 963, 375–383.
Marcheselli, V.L., Rossowska, M., Braquet, P., and Bazan, N.G. (1989)Trans. Am. Soc. Neurochem. 20, 135.
Bazan, N.G., Marcheselli, V.L., Braquet, P., and Cluzel, J.M. (1989)Soc. Neurosci. 15, 681.
Marcheselli, V.L., Rossowska, M., Domingo, M.T., Braquet, P., and Bazan, N.G. (1990)J. Biol. Chem. 265, 9140–9145.
Homma, H., Tokumura, A., and Hanahan, D.J. (1987)J. Biol. Chem. 262, 10582–10587.
Henson, P.M. (1987) inPlatelet-Activating Factor and Related Lipid Mediators (Snyder, F., ed.) pp. 255–271, Plenum Press, New York.
Bussolino, F., Gremo, F., Tetta, C., Pescarmona, G.P., and Camussi, G. (1986)J. Biol. Chem. 261, 16502–16508.
Sisson, J.H., Prescott, S.M., McIntyre, T.M., and Zimmerman, G.A. (1987)J. Immunol. 138, 3918–3926.
Patrignani, P., Valitutti, S., Aiello, F., and Musiani, P. (1987)Biochem. Biophys. Res. Commun. 148, 802–810.
Herschman, H.R. (1989)Trends in Biochem. Sci. 14, 455–458.
Curran, T., and Morgan, J.I. (1987)Bio Essays 7, 255–258.
Bohmann, D., Bos, T.J., Admon, A., Nishimura, T., Vogt, P.K., and Tjian, R. (1987)Science 238, 1386–1392.
Franza Jr., R.B., Rauscher III, F.J., Josephs, S.F., and Curran, T. (1988)Science 239, 1150–1153.
Rauscher, F.J., Cohen, D.R., Curran, T., Bos, T.J., Vogt, P.K., Bohmann, D., Tjian, R., and Franza Jr., R.B. (1988)Science 240, 1010–1016.
Greenberg, M.E., Ziff, E.B., and Greene, L.A. (1986)Science 234, 80–83.
Morgan, J., Cohen, D., Hempstead, J., and Curran, T. (1987)Science 237, 192–197.
Saffen, D.W., Cole, A.J., Worley, P.F., Christy B.A., Ryder, K., and Baraban, J.M. (1988)Proc. Natl. Acad. Sci. USA 85, 7795–7799.
Le Gal La Salle, G. (1988)Neurosci. Lett. 88, 127–130.
Daval, J.-L., Nakajima, T., Gleiter, C.H., Post, R., and Marangos, P.J. (1989)J. Neurochem. 52, 1954–1957.
Dragunow, M., Robertson, H.A., and Robertson, G.S. (1988)Exper. Neurol. 102, 261–263.
Jorgenson, M., Deckert, J., Wright, D., and Gehlert, D. (1989)Brain Res. 484, 393–398.
Squinto, S.P., Block, A.L., Braquet, P. and Bazan, N.G. (1989)J. Neurosci. Res. 24, 558–566.
Squinto, S.P., Braquet, P., Block, A.L., and Bazan, N.G. (1990)J. Mol. Neurosci. 2, 79–84.
Wu, B.-Y., Fodor, E.J.B., Edwards, R., and Rutter, W.J. (1989)J. Biol. Chem. 264, 9000–9003.
Sheng, M., Dougan, S.T., McFadden, G., and Greenberg, M.E. (1988)Mol. Cell Biol. 8, 2787–2798.
Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R.J., Rahmsdorf, H.J., Jonat, C., Herrlich, P., and Karin, M. (1987)Cell 49, 729–739.
Kouzarides, T., and Ziff, E. (1988)Nature 336, 646–651.
Sassone-Corsi, P., Ransone, L.J., Lamph, W.W., and Verma, I.M. (1988)Nature 336, 692–695.
Doucet, J.P., Squinto, S.P., and Bazan, N.G. (1990)Mol. Neurobiol. 4, 27–55.
Kornecki, E., and Ehrlich, Y.H. (1988),Science 240, 1792–1794.
Spinnewyn, B., and Blavet, N., Clostre, F., Bazan, N.G., and Braquet, P. (1987)Prostaglandins 34, 337–349.
Allan, G., and Bazan, N.G. (1989)Soc. Neurosci. 15, 842.
Allan, G., and Bazan, N.G. (1990)FASEB J. 4, A2149.
Doucet, J.P., and Bazan, N.G. (1990)FASEB J. 4, A1815.
Author information
Authors and Affiliations
About this article
Cite this article
Bazan, N.G., Squinto, S.P., Braquet, P. et al. Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: Intracellular PAF-binding sites and activation of a fos/jun/AP-1 transcriptional signaling system. Lipids 26, 1236–1242 (1991). https://doi.org/10.1007/BF02536539
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536539